Case Study: Providing access to COVID-19 treatment in the US

A newly established biotech firm with an innovative COVID-19 treatment sought emergency use authorization in the US while supporting healthcare professionals with limited respiratory treatment options. To facilitate early access, particularly in the US, the company approached Clinigen for assistance. While awaiting FDA approval, they aimed to support HCPs and aid patients with respiratory problems.

Read the case study to learn how Clinigen provided the treatment free of charge under Early Access regulations in the US.